Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
Ingredion appears to have lost significant market position or operational control in Pakistan's corn sector to competitor Nishat, indicating supply chain and competitive risks in a key sourcing region.
Ingredion missed Q3 2025 revenue estimates, indicating potential demand or operational challenges that could impact ingredient supply reliability.
Ingredion is reassessing its business operations in response to surge in product reformulations by customers, indicating potential supply chain demand volatility and need for operational adaptation.
Ingredion's major acquisition attempt of Tate & Lyle introduces integration risks, market consolidation effects, and potential supply chain disruption during the merger process.
Ingredion's acquisition offer for Tate & Lyle presents medium supply chain risk due to integration complexity, operational consolidation, and potential market concentration concerns.
Ingredion's $3.7 billion acquisition bid for Tate & Lyle represents a material supply chain consolidation event requiring assessment of integration risks and market impact.
Ingredion's $3.7 billion acquisition bid for Tate & Lyle represents a significant industry consolidation with potential supply chain integration risks and market concentration implications.
Ownership change clarification at Ingredion's Rafhan Maize subsidiary in Pakistan presents medium supply chain risk due to potential governance and operational implications in a key regional manufacturing facility.
Ingredion's proposed all-cash acquisition of Tate & Lyle represents a significant supply chain and operational integration risk requiring monitoring of post-merger execution.
Ingredion's acquisition of Tate & Lyle represents a significant consolidation in the ingredients supply sector with moderate integration and market concentration risks.
insidermonkey.com: Ingredion ( INGR ) Completes $165M Sale of Rafhan Maize S...; wandtv.com: Tate & Lyle bought for $5B by Ingredion Incorporated | Lo...; nutraingredients.com: Tate & Lyle agrees to takeover by Ingredion
GDELTNo issues detected across 2 sources
Top origins: Thailand, China, Singapore. Period: 2023-07-01 to 2026-07-01
ImportYeti (US Customs)No issues detected across 1 source
Penalties: $99000. Quarters non-compliant: 12. Programs: CAA, CWA, RCRA
Penalties: $80000. Quarters non-compliant: 6. Programs: CAA, CWA, RCRA
Penalties: $3000. Quarters non-compliant: 8. Programs: CAA, CWA, RCRA
Penalties: $0. Quarters non-compliant: 5. Programs: CAA, CWA, RCRA
Penalties: $5500. Quarters non-compliant: 0. Programs: CAA, CWA, RCRA
Penalties: $2450. Quarters non-compliant: 0. Programs: CAA, CWA, RCRA
INGREDION INCORPORATED: 12 qtrs non-compliance, $99000 penalties; INGREDION INCORPORATED: 7 qtrs non-compliance, $80000 penalties; INGREDION INC: 5 qtrs non-compliance, $0 penalties
EPA ECHORisks tied to the location of this facility.
Political stability: 0.03, Rule of law: 1.33, Corruption control: 1.12
World Bank WGI 2023No issues detected across 2 sources
Salmonella Infantis in poultry is directly relevant to Ingredion's supply chain as poultry-derived ingredients (gelatin, collagen, flavors) and cross-contamination risks in shared facilities could compromise product safety and trigger recalls.
Measles outbreaks across multiple US states could disrupt Ingredion's workforce availability and operations through employee illness, quarantine requirements, and potential facility closures, though the disease poses no direct threat to product safety or raw materials.
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: salmonella
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: botulism
CICLOSPORIASIS β EEUU: (MULTIESTADOS) BROTE EN EXPANSIΓN, CONSUMO DE LECHUGA DE CADENA DE RESTAURANTES ; EQUINE INFECTIOUS ANEMIA - USA (12): (FLORIDA) HORSE; ANTIMICROBIAL ENVIRONMENTAL CONTAMINATION (60): MICROPLASTICS, ANTIMICROBIAL RESISTANCE, BIOFILMS, WASTEWATER TREATMENT
WHO/CDC/ProMED